

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.92083630 |
| 2 | establishment of integrated proviral latency (GO:0075713) | 4.71280517 |
| 3 | cullin deneddylation (GO:0010388) | 4.61784421 |
| 4 | protein deneddylation (GO:0000338) | 4.58343204 |
| 5 | viral mRNA export from host cell nucleus (GO:0046784) | 4.39889167 |
| 6 | establishment of viral latency (GO:0019043) | 4.30686251 |
| 7 | COPI coating of Golgi vesicle (GO:0048205) | 4.22645168 |
| 8 | Golgi transport vesicle coating (GO:0048200) | 4.22645168 |
| 9 | peptidyl-arginine methylation (GO:0018216) | 4.18355561 |
| 10 | peptidyl-arginine N-methylation (GO:0035246) | 4.18355561 |
| 11 | histone arginine methylation (GO:0034969) | 4.11674235 |
| 12 | de novo posttranslational protein folding (GO:0051084) | 3.87477535 |
| 13 | positive regulation of mitochondrial fission (GO:0090141) | 3.85148855 |
| 14 | de novo protein folding (GO:0006458) | 3.82142834 |
| 15 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.73839845 |
| 16 | metallo-sulfur cluster assembly (GO:0031163) | 3.72909575 |
| 17 | iron-sulfur cluster assembly (GO:0016226) | 3.72909575 |
| 18 | DNA strand elongation (GO:0022616) | 3.70622807 |
| 19 | protein maturation by protein folding (GO:0022417) | 3.69818074 |
| 20 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.65569685 |
| 21 | formation of translation preinitiation complex (GO:0001731) | 3.61680676 |
| 22 | mitochondrial fusion (GO:0008053) | 3.58601458 |
| 23 | DNA ligation (GO:0006266) | 3.56550832 |
| 24 | tRNA methylation (GO:0030488) | 3.55273815 |
| 25 | tRNA aminoacylation for protein translation (GO:0006418) | 3.51076816 |
| 26 | proteasome assembly (GO:0043248) | 3.47848120 |
| 27 | proline biosynthetic process (GO:0006561) | 3.46881352 |
| 28 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.44931088 |
| 29 | negative regulation of ligase activity (GO:0051352) | 3.44448411 |
| 30 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.44448411 |
| 31 | amino acid activation (GO:0043038) | 3.43967369 |
| 32 | tRNA aminoacylation (GO:0043039) | 3.43967369 |
| 33 | ribosome assembly (GO:0042255) | 3.43398886 |
| 34 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.41742144 |
| 35 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.40877948 |
| 36 | glycolytic process (GO:0006096) | 3.37216828 |
| 37 | DNA unwinding involved in DNA replication (GO:0006268) | 3.35599092 |
| 38 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.31047523 |
| 39 | DNA replication initiation (GO:0006270) | 3.23441239 |
| 40 | mitotic nuclear envelope reassembly (GO:0007084) | 3.22086054 |
| 41 | nuclear envelope reassembly (GO:0031468) | 3.22086054 |
| 42 | pentose-phosphate shunt (GO:0006098) | 3.19502595 |
| 43 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.13975391 |
| 44 | spliceosomal snRNP assembly (GO:0000387) | 3.10944357 |
| 45 | mitotic metaphase plate congression (GO:0007080) | 3.07544320 |
| 46 | NADPH regeneration (GO:0006740) | 3.06920678 |
| 47 | mitotic nuclear envelope disassembly (GO:0007077) | 3.04336404 |
| 48 | IMP biosynthetic process (GO:0006188) | 3.00010221 |
| 49 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.96293667 |
| 50 | L-serine metabolic process (GO:0006563) | 2.95808434 |
| 51 | positive regulation of ligase activity (GO:0051351) | 2.95343791 |
| 52 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.91382728 |
| 53 | regulation of spindle organization (GO:0090224) | 2.91258382 |
| 54 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.90245273 |
| 55 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.87977224 |
| 56 | ncRNA 3-end processing (GO:0043628) | 2.84648941 |
| 57 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.84452402 |
| 58 | dosage compensation (GO:0007549) | 2.84368181 |
| 59 | regulation of mitochondrial translation (GO:0070129) | 2.84324383 |
| 60 | maturation of 5.8S rRNA (GO:0000460) | 2.82666477 |
| 61 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.80620405 |
| 62 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.80262600 |
| 63 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.80262600 |
| 64 | rRNA modification (GO:0000154) | 2.79438535 |
| 65 | tricarboxylic acid cycle (GO:0006099) | 2.79300732 |
| 66 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.79264426 |
| 67 | ribosome biogenesis (GO:0042254) | 2.77756399 |
| 68 | polyamine biosynthetic process (GO:0006596) | 2.77596998 |
| 69 | nuclear envelope disassembly (GO:0051081) | 2.76482537 |
| 70 | membrane disassembly (GO:0030397) | 2.76482537 |
| 71 | UV protection (GO:0009650) | 2.76465288 |
| 72 | regulation of ligase activity (GO:0051340) | 2.75508591 |
| 73 | tRNA modification (GO:0006400) | 2.74819002 |
| 74 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.74596537 |
| 75 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.74596537 |
| 76 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.74596537 |
| 77 | mitochondrial DNA metabolic process (GO:0032042) | 2.74254360 |
| 78 | base-excision repair (GO:0006284) | 2.74245620 |
| 79 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.73983779 |
| 80 | regulation of mitotic spindle organization (GO:0060236) | 2.73761194 |
| 81 | purine ribonucleotide transport (GO:0015868) | 2.73173115 |
| 82 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.72580974 |
| 83 | regulation of translational fidelity (GO:0006450) | 2.71569347 |
| 84 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.71552637 |
| 85 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.71517315 |
| 86 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.71457522 |
| 87 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.71457522 |
| 88 | DNA double-strand break processing (GO:0000729) | 2.70724905 |
| 89 | monosaccharide biosynthetic process (GO:0046364) | 2.70342785 |
| 90 | snRNA processing (GO:0016180) | 2.69329230 |
| 91 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.69110095 |
| 92 | gluconeogenesis (GO:0006094) | 2.66929615 |
| 93 | telomere maintenance via recombination (GO:0000722) | 2.65020237 |
| 94 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.64934776 |
| 95 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.63661491 |
| 96 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.63659716 |
| 97 | 7-methylguanosine mRNA capping (GO:0006370) | 2.63584128 |
| 98 | regulation of coenzyme metabolic process (GO:0051196) | 2.63213798 |
| 99 | regulation of cofactor metabolic process (GO:0051193) | 2.63213798 |
| 100 | base-excision repair, AP site formation (GO:0006285) | 2.61596042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.35483665 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.80770402 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.75596780 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.69010802 |
| 5 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.57338457 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.48855307 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.46416032 |
| 8 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 3.12132844 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.10879722 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.91372087 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.81529698 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.69753777 |
| 13 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.69538533 |
| 14 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.53232633 |
| 15 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.51197221 |
| 16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.47552825 |
| 17 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.45052381 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.39778541 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.39165586 |
| 20 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.34861202 |
| 21 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 2.25605233 |
| 22 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.21518343 |
| 23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.17164838 |
| 24 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.12457548 |
| 25 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.12338702 |
| 26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.12177664 |
| 27 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.08754394 |
| 28 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.05425772 |
| 29 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.05414257 |
| 30 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 2.03770761 |
| 31 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.02067937 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.00736900 |
| 33 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99791415 |
| 34 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.91492550 |
| 35 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.91163924 |
| 36 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.89418906 |
| 37 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.85834873 |
| 38 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.85822977 |
| 39 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.85087403 |
| 40 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.84675782 |
| 41 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.81995515 |
| 42 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.75829506 |
| 43 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.75730380 |
| 44 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.74528058 |
| 45 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.74485083 |
| 46 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.72645667 |
| 47 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.66165337 |
| 48 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.64989770 |
| 49 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.63248554 |
| 50 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.60203726 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57888303 |
| 52 | MYC_22102868_ChIP-Seq_BL_Human | 1.54009216 |
| 53 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53601960 |
| 54 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.50185532 |
| 55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49909130 |
| 56 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.47677050 |
| 57 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.44629469 |
| 58 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.40614436 |
| 59 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36760606 |
| 60 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.33087011 |
| 61 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.32595521 |
| 62 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.32237809 |
| 63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31288628 |
| 64 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.30624730 |
| 65 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.29519220 |
| 66 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.27292617 |
| 67 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.27076421 |
| 68 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.20996443 |
| 69 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.19920918 |
| 70 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19875235 |
| 71 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.19835365 |
| 72 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.18251380 |
| 73 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.17937594 |
| 74 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.17866141 |
| 75 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.17339890 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14892016 |
| 77 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.09651528 |
| 78 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.06507418 |
| 79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04027152 |
| 80 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.03981575 |
| 81 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03246464 |
| 82 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.03032527 |
| 83 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.02016158 |
| 84 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01490156 |
| 85 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.00646634 |
| 86 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.99612095 |
| 87 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98584862 |
| 88 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.98549565 |
| 89 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.97692641 |
| 90 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96801823 |
| 91 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.96018493 |
| 92 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.94581632 |
| 93 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.94062543 |
| 94 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.93047325 |
| 95 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.92634974 |
| 96 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.92449501 |
| 97 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.91883790 |
| 98 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88892822 |
| 99 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.87526845 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.86750744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 4.85150229 |
| 2 | MP0010094_abnormal_chromosome_stability | 4.47995270 |
| 3 | MP0008058_abnormal_DNA_repair | 4.15509427 |
| 4 | MP0003111_abnormal_nucleus_morphology | 3.73412995 |
| 5 | MP0003693_abnormal_embryo_hatching | 3.47692869 |
| 6 | MP0003221_abnormal_cardiomyocyte_apopto | 3.27672459 |
| 7 | MP0003077_abnormal_cell_cycle | 3.08119844 |
| 8 | MP0006035_abnormal_mitochondrial_morpho | 2.95522444 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.83550898 |
| 10 | MP0001529_abnormal_vocalization | 2.77348139 |
| 11 | MP0008007_abnormal_cellular_replicative | 2.58835904 |
| 12 | MP0008932_abnormal_embryonic_tissue | 2.55371486 |
| 13 | MP0009697_abnormal_copulation | 2.52888424 |
| 14 | MP0008260_abnormal_autophagy | 2.46751821 |
| 15 | MP0003656_abnormal_erythrocyte_physiolo | 2.24281836 |
| 16 | MP0000358_abnormal_cell_content/ | 2.13320011 |
| 17 | MP0008789_abnormal_olfactory_epithelium | 2.09029544 |
| 18 | MP0005394_taste/olfaction_phenotype | 2.08841481 |
| 19 | MP0005499_abnormal_olfactory_system | 2.08841481 |
| 20 | MP0003786_premature_aging | 2.07946787 |
| 21 | MP0006036_abnormal_mitochondrial_physio | 2.06877094 |
| 22 | MP0004957_abnormal_blastocyst_morpholog | 2.02290134 |
| 23 | MP0005058_abnormal_lysosome_morphology | 1.93735777 |
| 24 | MP0001730_embryonic_growth_arrest | 1.80226273 |
| 25 | MP0000749_muscle_degeneration | 1.67894702 |
| 26 | MP0003186_abnormal_redox_activity | 1.67458456 |
| 27 | MP0004233_abnormal_muscle_weight | 1.65787305 |
| 28 | MP0000350_abnormal_cell_proliferation | 1.57925638 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 1.56889847 |
| 30 | MP0000313_abnormal_cell_death | 1.54640808 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.51764430 |
| 32 | MP0005330_cardiomyopathy | 1.49773254 |
| 33 | MP0001727_abnormal_embryo_implantation | 1.49715203 |
| 34 | MP0000751_myopathy | 1.47878163 |
| 35 | MP0003315_abnormal_perineum_morphology | 1.45972162 |
| 36 | MP0002080_prenatal_lethality | 1.38492113 |
| 37 | MP0001849_ear_inflammation | 1.38282381 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.38113473 |
| 39 | MP0002269_muscular_atrophy | 1.28689758 |
| 40 | MP0000750_abnormal_muscle_regeneration | 1.26771489 |
| 41 | MP0005384_cellular_phenotype | 1.22987731 |
| 42 | MP0009840_abnormal_foam_cell | 1.18611954 |
| 43 | MP0001661_extended_life_span | 1.13777428 |
| 44 | MP0005501_abnormal_skin_physiology | 1.13020143 |
| 45 | MP0000747_muscle_weakness | 1.12342627 |
| 46 | MP0002653_abnormal_ependyma_morphology | 1.11143023 |
| 47 | MP0005380_embryogenesis_phenotype | 1.10354046 |
| 48 | MP0001672_abnormal_embryogenesis/_devel | 1.10354046 |
| 49 | MP0003718_maternal_effect | 1.08104790 |
| 50 | MP0002019_abnormal_tumor_incidence | 1.07503831 |
| 51 | MP0001764_abnormal_homeostasis | 1.07241732 |
| 52 | MP0005621_abnormal_cell_physiology | 1.06280405 |
| 53 | MP0002332_abnormal_exercise_endurance | 1.04705454 |
| 54 | MP0003329_amyloid_beta_deposits | 1.04523019 |
| 55 | MP0009278_abnormal_bone_marrow | 1.04297718 |
| 56 | MP0000343_altered_response_to | 1.03962600 |
| 57 | MP0000604_amyloidosis | 0.96078388 |
| 58 | MP0001853_heart_inflammation | 0.90208748 |
| 59 | MP0003984_embryonic_growth_retardation | 0.89742714 |
| 60 | MP0003137_abnormal_impulse_conducting | 0.87008890 |
| 61 | MP0000490_abnormal_crypts_of | 0.85336972 |
| 62 | MP0001270_distended_abdomen | 0.82632312 |
| 63 | MP0002396_abnormal_hematopoietic_system | 0.80779049 |
| 64 | MP0001697_abnormal_embryo_size | 0.78626519 |
| 65 | MP0002088_abnormal_embryonic_growth/wei | 0.78229804 |
| 66 | MP0002090_abnormal_vision | 0.78204819 |
| 67 | MP0005623_abnormal_meninges_morphology | 0.78189804 |
| 68 | MP0005266_abnormal_metabolism | 0.78168918 |
| 69 | MP0002132_abnormal_respiratory_system | 0.77543898 |
| 70 | MP0001545_abnormal_hematopoietic_system | 0.77259622 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 0.77259622 |
| 72 | MP0000858_altered_metastatic_potential | 0.76219080 |
| 73 | MP0002722_abnormal_immune_system | 0.75448077 |
| 74 | MP0003303_peritoneal_inflammation | 0.73264438 |
| 75 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72426302 |
| 76 | MP0005187_abnormal_penis_morphology | 0.70733247 |
| 77 | MP0003385_abnormal_body_wall | 0.70479479 |
| 78 | MP0009763_increased_sensitivity_to | 0.68982732 |
| 79 | MP0000689_abnormal_spleen_morphology | 0.68062169 |
| 80 | MP0002970_abnormal_white_adipose | 0.67601140 |
| 81 | MP0010307_abnormal_tumor_latency | 0.66847118 |
| 82 | MP0000372_irregular_coat_pigmentation | 0.64894575 |
| 83 | MP0002085_abnormal_embryonic_tissue | 0.62915232 |
| 84 | MP0008873_increased_physiological_sensi | 0.62827925 |
| 85 | MP0006082_CNS_inflammation | 0.61987027 |
| 86 | MP0005645_abnormal_hypothalamus_physiol | 0.61833242 |
| 87 | MP0002084_abnormal_developmental_patter | 0.60512020 |
| 88 | MP0001915_intracranial_hemorrhage | 0.59759893 |
| 89 | MP0005165_increased_susceptibility_to | 0.59249780 |
| 90 | MP0001243_abnormal_dermal_layer | 0.58429747 |
| 91 | MP0002086_abnormal_extraembryonic_tissu | 0.58335828 |
| 92 | MP0000759_abnormal_skeletal_muscle | 0.58297303 |
| 93 | MP0004197_abnormal_fetal_growth/weight/ | 0.57902175 |
| 94 | MP0002429_abnormal_blood_cell | 0.55899377 |
| 95 | MP0002751_abnormal_autonomic_nervous | 0.55797594 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 0.55505692 |
| 97 | MP0000598_abnormal_liver_morphology | 0.55130415 |
| 98 | MP0004808_abnormal_hematopoietic_stem | 0.55098281 |
| 99 | MP0005423_abnormal_somatic_nervous | 0.54737101 |
| 100 | MP0009785_altered_susceptibility_to | 0.54514805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Microvesicular hepatic steatosis (HP:0001414) | 4.75675045 |
| 2 | Cholecystitis (HP:0001082) | 4.51534807 |
| 3 | Abnormal gallbladder physiology (HP:0012438) | 4.51534807 |
| 4 | Abnormality of glycolysis (HP:0004366) | 4.06473265 |
| 5 | Progressive external ophthalmoplegia (HP:0000590) | 3.99016692 |
| 6 | Cortical dysplasia (HP:0002539) | 3.75168741 |
| 7 | Increased serum pyruvate (HP:0003542) | 3.72344123 |
| 8 | Ragged-red muscle fibers (HP:0003200) | 3.65212960 |
| 9 | Progressive muscle weakness (HP:0003323) | 3.64822084 |
| 10 | Abnormality of the anterior horn cell (HP:0006802) | 3.34683674 |
| 11 | Degeneration of anterior horn cells (HP:0002398) | 3.34683674 |
| 12 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.99912103 |
| 13 | Reticulocytosis (HP:0001923) | 2.80761370 |
| 14 | Squamous cell carcinoma (HP:0002860) | 2.67896394 |
| 15 | Exercise-induced muscle cramps (HP:0003710) | 2.63604094 |
| 16 | Termporal pattern (HP:0011008) | 2.57910146 |
| 17 | Insidious onset (HP:0003587) | 2.57910146 |
| 18 | Loss of speech (HP:0002371) | 2.57727865 |
| 19 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.57478925 |
| 20 | Abnormal protein glycosylation (HP:0012346) | 2.57478925 |
| 21 | Abnormal glycosylation (HP:0012345) | 2.57478925 |
| 22 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.57478925 |
| 23 | Reduced antithrombin III activity (HP:0001976) | 2.57428752 |
| 24 | Type I transferrin isoform profile (HP:0003642) | 2.56423905 |
| 25 | Cholelithiasis (HP:0001081) | 2.53806698 |
| 26 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.52649976 |
| 27 | Abnormal number of erythroid precursors (HP:0012131) | 2.50845940 |
| 28 | Rough bone trabeculation (HP:0100670) | 2.50121476 |
| 29 | Hepatocellular necrosis (HP:0001404) | 2.48865232 |
| 30 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.41601150 |
| 31 | Autoamputation (HP:0001218) | 2.40175765 |
| 32 | Increased intramyocellular lipid droplets (HP:0012240) | 2.38827953 |
| 33 | Abnormality of the motor neurons (HP:0002450) | 2.37958754 |
| 34 | Abnormal neuron morphology (HP:0012757) | 2.37958754 |
| 35 | Exercise intolerance (HP:0003546) | 2.36270557 |
| 36 | Abnormality of alanine metabolism (HP:0010916) | 2.32184904 |
| 37 | Hyperalaninemia (HP:0003348) | 2.32184904 |
| 38 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.32184904 |
| 39 | Increased serum lactate (HP:0002151) | 2.29413511 |
| 40 | Increased muscle lipid content (HP:0009058) | 2.24306837 |
| 41 | Poikiloderma (HP:0001029) | 2.22787878 |
| 42 | Retinal dysplasia (HP:0007973) | 2.22315294 |
| 43 | Upper limb muscle weakness (HP:0003484) | 2.21415002 |
| 44 | Thoracic kyphosis (HP:0002942) | 2.21281699 |
| 45 | Hepatic necrosis (HP:0002605) | 2.20626805 |
| 46 | Entropion (HP:0000621) | 2.18512162 |
| 47 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.17545739 |
| 48 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.15127856 |
| 49 | Abnormal gallbladder morphology (HP:0012437) | 2.14900068 |
| 50 | High anterior hairline (HP:0009890) | 2.14159575 |
| 51 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.13234538 |
| 52 | Lactic acidosis (HP:0003128) | 2.12785104 |
| 53 | Progressive hearing impairment (HP:0001730) | 2.12589362 |
| 54 | Postnatal microcephaly (HP:0005484) | 2.11421237 |
| 55 | Hyperacusis (HP:0010780) | 2.10599934 |
| 56 | Diminished motivation (HP:0000745) | 2.10216240 |
| 57 | Emotional lability (HP:0000712) | 2.04828978 |
| 58 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.02441852 |
| 59 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.02441852 |
| 60 | Abnormality of reticulocytes (HP:0004312) | 2.02366070 |
| 61 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.01526013 |
| 62 | Athetosis (HP:0002305) | 2.00467736 |
| 63 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.00353551 |
| 64 | Apathy (HP:0000741) | 1.99076310 |
| 65 | Insomnia (HP:0100785) | 1.97199119 |
| 66 | Esophageal neoplasm (HP:0100751) | 1.96247664 |
| 67 | Neoplasm of head and neck (HP:0012288) | 1.96247664 |
| 68 | Myoglobinuria (HP:0002913) | 1.94502337 |
| 69 | Rhabdomyolysis (HP:0003201) | 1.94046892 |
| 70 | Combined immunodeficiency (HP:0005387) | 1.93667612 |
| 71 | Opisthotonus (HP:0002179) | 1.92574475 |
| 72 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.91127521 |
| 73 | Abnormal trabecular bone morphology (HP:0100671) | 1.91021866 |
| 74 | Sensory axonal neuropathy (HP:0003390) | 1.90214914 |
| 75 | Hypoplasia of the brainstem (HP:0002365) | 1.87711633 |
| 76 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.87711633 |
| 77 | Neuronal loss in central nervous system (HP:0002529) | 1.85924044 |
| 78 | Upper motor neuron abnormality (HP:0002127) | 1.85894204 |
| 79 | Multiple enchondromatosis (HP:0005701) | 1.84512350 |
| 80 | Death in infancy (HP:0001522) | 1.84403360 |
| 81 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.82571860 |
| 82 | Hand muscle atrophy (HP:0009130) | 1.81505312 |
| 83 | Severe combined immunodeficiency (HP:0004430) | 1.79901557 |
| 84 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.79387940 |
| 85 | Limb-girdle muscle atrophy (HP:0003797) | 1.78370138 |
| 86 | Prolonged neonatal jaundice (HP:0006579) | 1.77487697 |
| 87 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.74984801 |
| 88 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.74984801 |
| 89 | Abnormality of glycolipid metabolism (HP:0010969) | 1.74984801 |
| 90 | Hepatosplenomegaly (HP:0001433) | 1.72706955 |
| 91 | Secondary amenorrhea (HP:0000869) | 1.71746867 |
| 92 | Aplastic anemia (HP:0001915) | 1.70338763 |
| 93 | Abnormality of the columella (HP:0009929) | 1.69739555 |
| 94 | Mitochondrial inheritance (HP:0001427) | 1.69147743 |
| 95 | Increased CSF lactate (HP:0002490) | 1.67735613 |
| 96 | Upper limb amyotrophy (HP:0009129) | 1.67711684 |
| 97 | Distal upper limb amyotrophy (HP:0007149) | 1.67711684 |
| 98 | Abnormality of the gallbladder (HP:0005264) | 1.66354029 |
| 99 | Hyperammonemia (HP:0001987) | 1.66047511 |
| 100 | Progressive microcephaly (HP:0000253) | 1.64955052 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.28650298 |
| 2 | PIM2 | 3.44879398 |
| 3 | PBK | 3.40987465 |
| 4 | VRK2 | 3.34118851 |
| 5 | MAP4K2 | 2.95949774 |
| 6 | BCKDK | 2.90589444 |
| 7 | BUB1 | 2.80144383 |
| 8 | TESK2 | 2.65624484 |
| 9 | ARAF | 2.41870584 |
| 10 | TSSK6 | 2.25683495 |
| 11 | MAP2K7 | 2.13251344 |
| 12 | BCR | 2.10480941 |
| 13 | NEK1 | 2.09799797 |
| 14 | CSNK1G3 | 2.05740760 |
| 15 | SRPK1 | 2.04884902 |
| 16 | LIMK1 | 1.94640961 |
| 17 | TESK1 | 1.90010987 |
| 18 | IRAK3 | 1.89812365 |
| 19 | CSNK1A1L | 1.86911447 |
| 20 | SIK3 | 1.83875322 |
| 21 | TRIM28 | 1.82828834 |
| 22 | RAF1 | 1.76480763 |
| 23 | SMG1 | 1.75473425 |
| 24 | CLK1 | 1.67364024 |
| 25 | RPS6KA4 | 1.62095819 |
| 26 | CCNB1 | 1.61727352 |
| 27 | CSNK1G2 | 1.31785306 |
| 28 | CSNK1G1 | 1.27876539 |
| 29 | SCYL2 | 1.26888299 |
| 30 | FLT3 | 1.25521585 |
| 31 | TTK | 1.23505031 |
| 32 | DAPK1 | 1.23362433 |
| 33 | VRK1 | 1.20963139 |
| 34 | PKN2 | 1.20463724 |
| 35 | EIF2AK1 | 1.19442848 |
| 36 | CDC7 | 1.15316838 |
| 37 | ICK | 1.12903347 |
| 38 | DYRK3 | 1.12137607 |
| 39 | PAK4 | 1.11119280 |
| 40 | MAP3K4 | 1.10575837 |
| 41 | ATR | 1.08659654 |
| 42 | PAK6 | 1.07155237 |
| 43 | ERBB3 | 1.03089893 |
| 44 | KSR2 | 1.00743589 |
| 45 | AURKA | 0.99906565 |
| 46 | BRAF | 0.91486559 |
| 47 | KDR | 0.87059742 |
| 48 | ERN1 | 0.86511558 |
| 49 | PLK1 | 0.85349791 |
| 50 | CDK14 | 0.81795180 |
| 51 | STK10 | 0.81522664 |
| 52 | KSR1 | 0.80836745 |
| 53 | CDK7 | 0.75292281 |
| 54 | AURKB | 0.71524294 |
| 55 | CDK18 | 0.69612482 |
| 56 | MAP3K8 | 0.67481614 |
| 57 | PDK2 | 0.67125722 |
| 58 | PRPF4B | 0.66541866 |
| 59 | TAOK2 | 0.64000795 |
| 60 | PAK2 | 0.63520452 |
| 61 | CDK11A | 0.62937461 |
| 62 | RPS6KA5 | 0.61938502 |
| 63 | CDK15 | 0.61536491 |
| 64 | CHEK1 | 0.61218678 |
| 65 | LMTK2 | 0.60544577 |
| 66 | MAP3K5 | 0.60387040 |
| 67 | AKT2 | 0.59941006 |
| 68 | MST4 | 0.56781956 |
| 69 | PAK1 | 0.54743429 |
| 70 | PLK3 | 0.53186761 |
| 71 | ABL2 | 0.52105294 |
| 72 | CDK4 | 0.49698172 |
| 73 | MST1R | 0.49075152 |
| 74 | BRSK1 | 0.47795201 |
| 75 | PLK4 | 0.47317523 |
| 76 | ATM | 0.44197063 |
| 77 | EPHA3 | 0.43963007 |
| 78 | BRD4 | 0.43509050 |
| 79 | CDK9 | 0.41657943 |
| 80 | MAP3K10 | 0.41469741 |
| 81 | EPHA2 | 0.41240995 |
| 82 | DAPK3 | 0.40690300 |
| 83 | PINK1 | 0.40551407 |
| 84 | MOS | 0.38690063 |
| 85 | MAP3K11 | 0.38536964 |
| 86 | TTN | 0.36525913 |
| 87 | PRKCI | 0.35514141 |
| 88 | LRRK2 | 0.34862976 |
| 89 | IRAK4 | 0.34776314 |
| 90 | EIF2AK3 | 0.34318964 |
| 91 | CSNK2A1 | 0.33853125 |
| 92 | TAOK3 | 0.32956563 |
| 93 | CHEK2 | 0.32672946 |
| 94 | NEK9 | 0.30639072 |
| 95 | MAPK11 | 0.28681486 |
| 96 | CDK2 | 0.28345063 |
| 97 | BLK | 0.28235169 |
| 98 | CDK6 | 0.26563498 |
| 99 | CSNK2A2 | 0.25942005 |
| 100 | MARK3 | 0.25562385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.64246008 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.35758101 |
| 3 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.26793765 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 3.23346027 |
| 5 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.80086961 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.71970251 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.66438848 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.56639001 |
| 9 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.55940028 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.39362135 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.28551408 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.24588087 |
| 13 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.07425178 |
| 14 | RNA transport_Homo sapiens_hsa03013 | 2.04352759 |
| 15 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.02587612 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 2.00548005 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.99534839 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.97351254 |
| 19 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.87753320 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.82581083 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.64083696 |
| 22 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.61809687 |
| 23 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.56818587 |
| 24 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.56275297 |
| 25 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.55778726 |
| 26 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.54872645 |
| 27 | Homologous recombination_Homo sapiens_hsa03440 | 1.54857143 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.54571975 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.53702847 |
| 30 | Cell cycle_Homo sapiens_hsa04110 | 1.51945996 |
| 31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.48075416 |
| 32 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.44701805 |
| 33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.40302644 |
| 34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.30950314 |
| 35 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.17199771 |
| 36 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.16578381 |
| 37 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.08247398 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05321344 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.04129808 |
| 40 | Galactose metabolism_Homo sapiens_hsa00052 | 1.01197758 |
| 41 | Purine metabolism_Homo sapiens_hsa00230 | 1.01009316 |
| 42 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.99589850 |
| 43 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.99581634 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98710509 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.94195024 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.93880293 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 0.93035704 |
| 48 | Parkinsons disease_Homo sapiens_hsa05012 | 0.92937472 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.90241518 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.89598700 |
| 51 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.89289677 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.88533882 |
| 53 | Bladder cancer_Homo sapiens_hsa05219 | 0.87508787 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85398206 |
| 55 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79171391 |
| 56 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.73774195 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71460396 |
| 58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70551244 |
| 59 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66868913 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 0.66557156 |
| 61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66440219 |
| 62 | Alcoholism_Homo sapiens_hsa05034 | 0.65078637 |
| 63 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64572777 |
| 64 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.64077295 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.63613805 |
| 66 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.63534088 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61196214 |
| 68 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.61146769 |
| 69 | Huntingtons disease_Homo sapiens_hsa05016 | 0.58185616 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.57266676 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55437872 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53074668 |
| 73 | Salmonella infection_Homo sapiens_hsa05132 | 0.52071032 |
| 74 | Basal transcription factors_Homo sapiens_hsa03022 | 0.51733198 |
| 75 | RNA degradation_Homo sapiens_hsa03018 | 0.51493484 |
| 76 | Apoptosis_Homo sapiens_hsa04210 | 0.49454325 |
| 77 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.49118779 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.46700466 |
| 79 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.45851076 |
| 80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45658951 |
| 81 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.45011776 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44465789 |
| 83 | Hepatitis B_Homo sapiens_hsa05161 | 0.44014342 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42655793 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42398985 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41831498 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.35689534 |
| 88 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.35153870 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32400696 |
| 90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.28056124 |
| 91 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.27775814 |
| 92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.27630466 |
| 93 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.27194991 |
| 94 | Protein export_Homo sapiens_hsa03060 | 0.25919951 |
| 95 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.25265019 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21729580 |
| 97 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.19415858 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.18577383 |
| 99 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.16957602 |
| 100 | Influenza A_Homo sapiens_hsa05164 | 0.16854985 |

